CompletedNot Applicable

The Validity of Kleinhauer Betke in Women With Known Hemoglobinopathy for Fetal-maternal Hemorrhage

Israel27 participantsStarted 2018-07-18

Plain-language summary

The aim of this study is to determine the validity of Kleinhauer Betke in women with known hemoglobinopathy for fetal-maternal hemorrhage.

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Pregnant with singleton fetus * Gestational age 34-42 * With or without known hemoglobinopathy Exclusion Criteria: * Known risk factor for fetal maternal hemorrhage

What they're measuring

Validity of Kleinhauer Betke test in Pregnant Women

Timeframe: 24 hours

Trial details

NCT IDNCT03591640

SponsorHillel Yaffe Medical Center

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

Primary completion2021-04-28

View on ClinicalTrials.gov More Fetal-Maternal Hemorrhage trials